These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antiangiogenic therapy for high-grade glioma. Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542 [TBL] [Abstract][Full Text] [Related]
25. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors. Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124 [TBL] [Abstract][Full Text] [Related]
26. Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas. Reiss SN; Yerram P; Modelevsky L; Grommes C J Immunother Cancer; 2017 Dec; 5(1):99. PubMed ID: 29254497 [TBL] [Abstract][Full Text] [Related]
27. CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway. Ampudia-Mesias E; Puerta-Martinez F; Bridges M; Zellmer D; Janeiro A; Strokes M; Sham YY; Taher A; Castro MG; Moertel CL; Pluhar GE; Olin MR Neurotherapeutics; 2021 Jul; 18(3):1980-1994. PubMed ID: 33829411 [TBL] [Abstract][Full Text] [Related]
28. Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study. Roci E; Cakani B; Brace G; Bushati T; Rroji A; Petrela M; Kaloshi G Med Arch; 2014; 68(2):140-3. PubMed ID: 24937942 [TBL] [Abstract][Full Text] [Related]
29. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment. Yi M; Jiao D; Qin S; Chu Q; Wu K; Li A Mol Cancer; 2019 Mar; 18(1):60. PubMed ID: 30925919 [TBL] [Abstract][Full Text] [Related]
30. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors. De Martin E; Michot JM; Papouin B; Champiat S; Mateus C; Lambotte O; Roche B; Antonini TM; Coilly A; Laghouati S; Robert C; Marabelle A; Guettier C; Samuel D J Hepatol; 2018 Jun; 68(6):1181-1190. PubMed ID: 29427729 [TBL] [Abstract][Full Text] [Related]
31. Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. Manca P; Corti F; Intini R; Mazzoli G; Miceli R; Germani MM; Bergamo F; Ambrosini M; Cristarella E; Cerantola R; Boccaccio C; Ricagno G; Ghelardi F; Randon G; Leoncini G; Milione M; Fassan M; Cremolini C; Lonardi S; Pietrantonio F Eur J Cancer; 2023 Jul; 187():15-24. PubMed ID: 37099945 [TBL] [Abstract][Full Text] [Related]
32. Investigational new drugs for brain cancer. Staedtke V; Bai RY; Laterra J Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161 [TBL] [Abstract][Full Text] [Related]